On July 4, Sinopharm Free Trade Zone (Beijing) International Pharmaceutical Distribution Center Co., Ltd. (Sinopharm-ftz), a subsidiary of Sinopharm Foreign Trade, and Lipoid, a world-leading supplier of pharmaceutical-grade phospholipids, signed a logistics service agreement in Beijing. Sinopharm-ftz will provide one-stop professional supply chain services for Lipoid's deep-frozen pharmaceutical products in China. General Manager of Sinopharm-ftz Li Zhaorui and Chairman of Lipoid China Dr. Balder Rebmann signed the agreement on behalf of both parties.

Centered on customized deep-frozen warehousing services, Sinopharm-ftz will tailor-built Asia's first standardized dedicated deep-frozen warehouse for pharmaceuticals (temperature control range: -15～-25℃) in the park for Lipoid. Relying on its professional pharmaceutical supply chain service system, it will fully undertake Lipoid's needs for import customs clearance, bonded storage and national logistics and transportation. In the future, the two parties will continue to deepen cooperation in the pharmaceutical supply chain field on this basis.

With the goal of "becoming an industry-leading international pharmaceutical supply chain service provider", Sinopharm-ftz will continuously improve service quality, enhance the resilience and safety of the pharmaceutical industry supply chain by integrating resources, provide key support for the localization of transnational pharmaceutical companies' supply chains in China, promote the efficient access of high-quality global pharmaceutical products to the Chinese market, and inject new impetus into the integrated development of globalization and localization of the pharmaceutical industry.

Founded in 1977 and headquartered in Germany, Lipoid is the world's only professional supplier with the mass production capacity of a full range of natural, hydrogenated and high-purity synthetic phospholipids. It has established distribution bases in 8 countries and owns 4 international production bases, focusing on the R&D and production of pharmaceutical-grade phospholipid products.